Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Biologically-derived Medicines on Demand

Solicitation Number: DARPA-BAA-11-71
Agency: Other Defense Agencies
Office: Defense Advanced Research Projects Agency
Location: Contracts Management Office
  • Print


There have been modifications to this notice. You are currently viewing the original synopsis. To view the most recent modification/amendment, click here
Added: Aug 30, 2011 8:29 am
The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs.

See Attached DARPA-BAA-11-71.

Please consult the list of document viewers if you cannot open a file.


Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Posted Date:
August 30, 2011
Description: DARPA-BAA-11-71
3701 North Fairfax Drive
Arlington, Virginia 22203-1714
Geoffrey Ling,